Novartis Institutes for BioMedical Research, Inc. 4
4 · Intellia Therapeutics, Inc. · Filed Dec 14, 2017
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2017-12-12$18.30/sh−1,523,000$27,870,900→ 4,129,903 total
Footnotes (2)
- [F1]The price reported in Column 4 is exclusive of any fees, commissions or other expenses.
- [F2]The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.